HBsAg clearance in chronic hepatitis B patients with add-on pegylated interferon alfa-2a to ongoing tenofovir treatment: A randomized controlled study

Autor:	Hamad Al Ashgar, Musthafa C Peedikayil, Mohammed Al Quaiz, Fahad Al Sohaibani, Abdulrahman Al Fadda, Mohammed Q Khan, Einar Thoralsson, Sahar Al Thawadi, Ahmed Al Jedai, Khalid Al Kahtani
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	Chronic hepatitis B clinical trial hepatitis B surface antigen clearance hepatitis B virus seroprevalence Diseases of the digestive system. Gastroenterology RC799-869
Zdroj:	The Saudi Journal of Gastroenterology, Vol 23, Iss 3, Pp 190-198 (2017)
Druh dokumentu:	article
ISSN:	1319-3767 1998-4049
DOI:	10.4103/sjg.SJG_541_16
Popis:	Background/Aims: The ideal end point of treatment for chronic hepatitis B virus (HBV) infection is sustained off-therapy hepatitis B surface antigen (HBsAg) loss with or even without seroconversion to anti-HBs. We investigated the role of adding PEGylated interferon (PEG IFN) to ongoing tenofovir treatment in chronic HBV patients for achieving HBsAg clearance. Patients and Methods: In this randomized controlled trial, chronic HBV patients who have been receiving tenofovir for >6 months with HBV viral load
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/e0f78f995fc44a318671c28dc6cc7ca0 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF